Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and New IOL Data at AAO

Source: Alcon

Alcon announced its plans to lead a wide range of informational and peer-to-peer educational programs at the American Academy of Ophthalmology (AAO) annual meeting on October 12-15 in San Francisco. The newly launched AcrySof IQ PanOptix Trifocal IOL, along with findings from the AAO IRIS (Intelligent Research in Sight) Registry, will be part of the scientific program. 

“We are thrilled to showcase PanOptix, the first and only advanced trifocal IOL approved in the U.S., at the meeting, underscoring our continued commitment to innovation,” Sergio Duplan, Region President, North America, said in a company news release. “However, our focus goes beyond just bringing new products to the market. We are also dedicated to ongoing learning about our current portfolio as shown with the AAO IRIS Registry, which has allowed us to use an unprecedented amount of real-world data to help validate the performance of our AcrySof platform.”

Showcasing PanOptix, the First and Only FDA-approved Advanced Trifocal IOL

PanOptix, which received FDA-approval in August, is the first and only advanced trifocal lens approved in the US. 20/20 near, intermediate and distance vision is now possible with this new lens. PanOptix has over 400,000 implants in more than 70 countries. Based on years of experience with the lens, Alcon plans to share best practices and hands-on training, including virtual reality kiosks at the Alcon booth where surgeons can learn first-hand about PanOptix and how it works. Additional highlights will include:

Clinical Presentation

  • E-Poster: Evaluation of the Binocular Depth of Focus of a New Trifocal IOL, R. P. Lehmann

Peer-to-Peer Learning

  • Feel the Thrill PanOptix launch event where surgeons hear from other surgeons in an interactive format (Saturday, October 12 at 5:30 PM Terra Gallery, 511 Harrison Street)
  • Surgeon2Surgeon Talks where clinical trial investigators will share their first-hand clinical experience with the new lens (Alcon Booth, #539)

Investigating the Real-World Performance of IOLs

Alcon has supported retrospective real-world evidence studies to better understand outcomes of its products. The studies used the American Academy of Ophthalmology IRIS Registry, the largest clinical specialty database in the world, and were completed in collaboration with Verana Health, the Academy’s data curation and analytics partner. As of September 1, 2019, the IRIS Registry included approximately 253 million patient visits, representing more than 61 million unique patients.

Clinical Presentations

  • Paper Presentation, Tuesday, October 15, 11:03 AM – 11:10 AM: Incidence of Monofocal Toric IOL Repositioning: Analysis of the AAO IRIS Registry; B.A. Kramer, J.P. Berdahl
  • Paper Presentation, Tuesday, October 15, 11:27 AM – 11:34 AM: The Potential Benefit of Lower-Powered Toric IOLs According to the Astigmatism Fix Database; B.A. Kramer
  • E-Poster: Incidence of YAG due to PCO Following IOL Implantation: An Analysis of AAO IRIS Registry; J.D. Horn
  • E-Poster: Description of Retrospective EHR-Based Registry Study to Correlate Toric IOL Biomechanics with Repositioning Incidence; B.A. Kramer
  • E-Poster: Description of a Retrospective Study Using EHR-Based Registry to Correlate IOL Biocompatibility with YAG; D.C. Terveen
  • E-Poster: Comparison of Time to PCO in Two Hydrophobic IOL Materials: An Analysis of the AAO Clinical Registry; B.L. Fisher

Providing Visualization Systems for Both Front and Back of the Eye to US Surgeons

Alcon’s revolutionary Ngenuity 3D Visualization System is now available for both the anterior and posterior segments. Clinical presentations about its real-world implementation in “heads-up” cataract surgery will take place during AAO. The Alcon booth will also feature other anterior segment visualization developments, including LuxOR Revalia Ophthalmic Microscope, which delivers enhanced visualization during all stages of ophthalmic surgery through unique and personalized LED illumination technology.

In addition, the latest generation of the Ngenuity 3D Visualization System with Datafusion for posterior segment surgery, which was recently launched, will be highlighted at the 5th Annual Retina Film Festival. This latest innovation includes a real-time display of the Constellation Vision System, the leading technology platform for vitreoretinal surgery. It also allows surgeons to control surgical parameters using the graphic user interface and foot pedal.   

Clinical Presentations

  • Paper Presentation, Sunday, October 13, 4:18 PM – 4:25 PM: Heads-Up Cataract Surgery: Complication Rates, Surgical Duration and Comparison with Traditional Microscopes, R. J. Weinstock
  • E-Poster: Heads-Up Cataract Surgery Using Ngenuity System, J. Nemcansky

Peer-to-Peer Learning

  • The 5th Annual Retina Exchange Film Festival, an engaging video-based program discussing the latest in surgical retina techniques (Saturday, October 12, 2019 at 5:45 PM, Yerba Buena Center for the Arts)
  • Surgeon2Surgeon Talks where surgeons will share their first-hand clinical experience with Ngenuity (Alcon Booth, #539)



Related Content